Primary central nervous system lymphoma in childhood presenting as progressive panhypopituitarism

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 2, 2001, Pages 130-133

  Silfen, Miriam E ^a   Garvin, James H ^a   Hays, Arthur P ^a   Starkman, Harold S ^b   Aranoff, Gaya S ^a   Levine, Lenore S ^a   Feldstein, Neil A ^a   Wong, Brian ^a   Oberfield, Sharon E ^a  

^a Department of Orthopaedic Surgery   (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

Author keywords

Diabetes insipidus; Growth hormone therapy; Panhypopituitarism; Primary CNS lymphoma

Indexed keywords

GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; TESTOSTERONE; THYROXINE;

ADOLESCENT; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CASE REPORT; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; CLINICAL FEATURE; DIABETES INSIPIDUS; DIAGNOSTIC IMAGING; FOLLOW UP; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONE DETERMINATION; HUMAN; HYPOPITUITARISM; LYMPHOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CYCLOPHOSPHAMIDE; CYTARABINE; DIABETES INSIPIDUS; DISEASE PROGRESSION; DOXORUBICIN; DWARFISM, PITUITARY; FALSE NEGATIVE REACTIONS; GENETIC PREDISPOSITION TO DISEASE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; HYPOTHYROIDISM; LYMPHOMA, HIGH-GRADE; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; PITUITARY HORMONES; PITUITARY NEOPLASMS; PREDNISONE; REMISSION INDUCTION; VINCRISTINE;

EID: 0035108628     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200102000-00013     Document Type: Article

References (25)

1. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993; 119:1093-1104.
2. Sonstein W, Tabaddor K, Llena JF. Solitary primary CNS lymphoma: long term survival following total resection. Med Oncol 1993; 15:61-65.
3. Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary brain lymphoma in the US. Cancer 1988; 62:2461-5.
4. Abrey LE, DeAngeles LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16:859-63.
5. Brada M, Hjiyiannakis D, Hines F, et al. Short intensive primary chemotherapy and radiotherapy in sporadic primary CNS lymphoma. Int J Radiat Oncol Biol Phys 1998; 40:1157-62.
6. Yang CP, Wan YL, Hung IJ. Successfully treated central nervous system Burkitt’s lymphoma with minimal extraneural disease in a child. J Formosan Med Assoc 1999; 98:66-9.
7. Samuels MA, De La Monte S. A 49-year-old man with hypopituitarism, multifocal neurologic defects and an intracranial mass. N Engl J Med 1994; 331:861-8.
8. Shaw JAM, Strachan FM, Sawers HA, et al. Non-Hodgkin lymphoma with panhypopituitarism, hyperprolactinaemia and sixth nerve palsy. J R Soc Med 1997; 90:274-5.
9. Boadle DJ, Tattersall MHN. Primary cerebral lymphoma: Presentation of eight cases and review of the literature. Aust N Z J Med 1989; 19:682-6.
10. Andiman WA, Eastman R, Martin KM, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985; 2:1390-3.
11. Ernberg I, Bjorkholm J, Zech L, et al. An EBV genome carrying pre-B cell leukemia in a homosexual man with characteristic karyotype and impaired EBV-specific immunity. J Clin Oncol 1986; 4:1481-8.
12. Cemeroglu AP, Blaivas M, Muraszko KM, et al. Lymphocytic hypophysitis presenting with diabetes insipidus in a 14 year old girl: case report and review of the literature. Eur J Pediatr 1997; 156:684-8.
13. Bettendorf M, Fehn M, Grulich-Henn J, et al. Lymphocytic hypophysitis with central diabetes insipidus and consequent panhypopituitarism preceding a multifocal, intracranial germinoma in a prepubertal girl. Eur J Pediatr 1999; 158:288-92.
14. Anonymous. Case records of the Massachusetts General Hospital. Weekly clinicopathologic exercises. Case 36-1994. A 49-year-old man with hypopituitarism, multifocal neurologic defects, and an intracranial mass (clinical conference). N Engl J Med 1994;331:861-8.
15. Jonkhoff AR, Huijgens PC, Schreuder WO, et al. Hypophyseal non-Hodgkin’s lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy. J Neurooncol 1993; 17:155-8.
16. Birch JM, Harley AL, Tricker KJ, et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 1994; 54:1298-1304.
17. Moshang Jr. T Is brain tumor recurrence increased in children treated with growth hormone? Trends Endocrinol Metab 1995; 6:205-9.
18. Tuffli GA, Johanson A, Rundle AC, et al. Lack of increased risk for extracranial, nonleukemic neoplasms in recipients of recombinant deoxyribonucleic acid growth hormone. J Clin Endocrinol Metab 1995; 80:1416-22.
19. Blethen SL, Allen DB, Graves D, et al. Safety of recombinant deoxyribonucleic acid -derived growth hormone: The national cooperative growth study experience. JCEM 1996; 81:1704-10.
20. Moshang Jr. T Use of growth hormone in children surviving cancer. Med Pediatr Oncol 1998; 31:170-2.
21. Estrov Z, Meir R, Barak Y, et al. Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts. J Clin Oncol 1991; 9:394-9.
22. Murphy WJ, Durum SK, Anver M, et al. Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma. Brain Behav Immun 1992; 6:355-64.
23. Forbes GM, Cohen AK. Primary cerebral lymphoma: an association with craniopharyngioma or cadaveric growth hormone therapy? Med J Aust 1992; 157:27-8.
24. Magnavita N, Teofili L, Leone G. Hodgkin’s lymphoma in a cyclist treated with growth hormone. Am J Hematol 1996; 52:65-6.
25. Lincoln DT, Temmin L, Al-Jarallah MA, et al. Primary ki-1 lymphoma of the skin: expression of growth hormone receptors. Nutrition 1995; 11:627-31.